Citations (177)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Breanne E. Biondi, Cynthia A. Frank, Ariadna Forray & Sandra A. Springer. (2021) Gender differences among criminal justice-involved persons living with HIV interested in extended-release naltrexone treatment. Substance Abuse 42:4, pages 905-911.
Read now
Read now
Tanya C. Saraiya, Martina Pavlicova, Mei-Chen Hu, Edward V. Nunes, Denise A. Hien & Aimee N. C. Campbell. (2020) Exploring gender differences among treatment-seekers who use opioids versus alcohol and other drugs. Women & Health 60:7, pages 821-838.
Read now
Read now
Ji-Yeun Park & Li-Tzy Wu. (2020) Sources of Misused Prescription Opioids and Their Association with Prescription Opioid Use Disorder in the United States: Sex and Age Differences. Substance Use & Misuse 55:6, pages 928-936.
Read now
Read now
George Pro, Jeff Utter, Jessica Cram & Julie Baldwin. (2020) Racial/Ethnic and Gender Differences in Associations of Medication-Assisted Therapy and Reduced Opioid Use between Outpatient Treatment Admission and Discharge. Journal of Psychoactive Drugs 52:2, pages 186-194.
Read now
Read now
Dawn E. Sugarman, Meghan E. Reilly, John M. Rodolico & Shelly F. Greenfield. (2019) Feasibility and Acceptability of a Gender-Specific Group Treatment for Men with Substance Use Disorders. Alcoholism Treatment Quarterly 37:4, pages 422-441.
Read now
Read now
Matthew Hanauer, Kathryn Sielbeck-Mathes & Lauren Berny. (2019) Invariance of a recovery capital scale across gender, ethnicity, and sexual orientation in a substance use disorder treatment program. The American Journal of Drug and Alcohol Abuse 45:3, pages 254-263.
Read now
Read now
Landhing M. Moran, William J. Kowalczyk, Karran A. Phillips, Massoud Vahabzadeh, Jia-Ling Lin, Mustapha Mezghanni, David H. Epstein & Kenzie L. Preston. (2018) Sex differences in daily life stress and craving in opioid-dependent patients. The American Journal of Drug and Alcohol Abuse 44:5, pages 512-523.
Read now
Read now
Celestina Barbosa-Leiker, Sterling McPherson, Matthew E. Layton, Ekaterina Burduli, John M. Roll & Walter Ling. (2018) Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment. The American Journal of Drug and Alcohol Abuse 44:4, pages 488-496.
Read now
Read now
Huang-Chi Lin, Peng-Wei Wang, Yi-Hsin Yang, Jih-Jin Tsai & Cheng-Fang Yen. (2016) Incarcerated intravenous heroin users: Predictors of post-release utilization of methadone maintenance treatment. Journal of Addictive Diseases 35:2, pages 109-118.
Read now
Read now
Maciej Gasior, Mary Bond & Richard Malamut. (2016) Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgraduate Medicine 128:1, pages 85-96.
Read now
Read now
Gerardo Flórez, Ana López-Durán, Yolanda Triñanes, Jesús Osorio, Jaime Fraga, José Manuel Fernández, Elisardo Becoña & Manuel Arrojo. (2015) First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment. Neuropsychiatric Disease and Treatment 11, pages 2431-2440.
Read now
Read now
BethanyK. Bracken, John Rodolico & KevinP. Hill. (2013) Sex, Age, and Progression of Drug Use in Adolescents Admitted for Substance Use Disorder Treatment in the Northeastern United States: Comparison With a National Survey. Substance Abuse 34:3, pages 263-272.
Read now
Read now
Shelly F. Greenfield, Amanda M. Cummings, Laura E. Kuper, Sara B. Wigderson & Mirka Koro-Ljungberg. (2013) A Qualitative Analysis of Women's Experiences in Single-Gender Versus Mixed-Gender Substance Abuse Group Therapy. Substance Use & Misuse 48:9, pages 750-760.
Read now
Read now
Huang-Chi Lin, Yu-Ping Chang, Peng-Wei Wang, Hung-Chi Wu, Chia-Nan Yen, Yi-Chun Yeh, Kuan-Sheng Chung, Hsun-Cheng Chang & Cheng-Fang Yen. (2013) Gender Differences in Heroin Users Receiving Methadone Maintenance Therapy in Taiwan. Journal of Addictive Diseases 32:2, pages 140-149.
Read now
Read now
Huang-Chi Lin, Kuei-Ying Chen, Peng-Wei Wang, Cheng-Fang Yen, Hung-Chi Wu, Chia-Nan Yen, Yi-Chun Yeh, Kung-shang Chung & Hsun-Cheng Chang. (2013) Predictors for Dropping-Out From Methadone Maintenance Therapy Programs Among Heroin Users in Southern Taiwan. Substance Use & Misuse 48:1-2, pages 181-191.
Read now
Read now
Edward V. Nunes. (2011) The Design and Analysis of Multisite Effectiveness Trials: A Decade of Progress in the National Drug Abuse Clinical Trials Network. The American Journal of Drug and Alcohol Abuse 37:5, pages 269-272.
Read now
Read now
Articles from other publishers (161)
Kendall Woodlief, Mia I. Allen, Jeremy C. Cornelissen, Matthew L. Banks, Amy Hauck Newman & Michael A. Nader. (2023) Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Neuropsychopharmacology 48:12, pages 1716-1723.
Crossref
Crossref
Jessica M. Illenberger, Francisco J. Flores-Ramirez, Glenn Pascasio, Alessandra Matzeu & Rémi Martin-Fardon. (2023) Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement. Neuropharmacology 239, pages 109685.
Crossref
Crossref
Suzanne Turner, Victoria M. Allen, Lisa Graves, Robert Tanguay, Courtney R. Green & Jocelynn L. Cook. (2023) Directive clinique no 443a : Opioïdes aux différentes étapes de la vie des femmes : Fertilité, contraception, douleur chronique et ménopause. Journal of Obstetrics and Gynaecology Canada 45:11, pages 102145.
Crossref
Crossref
Suzanne Turner, Victoria M. Allen, Lisa Graves, Robert Tanguay, Courtney R. Green & Jocelynn L. Cook. (2023) Guideline No. 443a: Opioid Use Throughout Women’s Lifespan: Fertility, Contraception, Chronic Pain, and Menopause. Journal of Obstetrics and Gynaecology Canada 45:11, pages 102143.
Crossref
Crossref
Osman Syed, Predrag Jancic, Adam B. Fink & Nebojsa Nick Knezevic. (2023) Drug Safety and Suicidality Risk of Chronic Pain Medications. Pharmaceuticals 16:10, pages 1497.
Crossref
Crossref
Kaitlyn M. Little & Therese A Kosten. (2023) Focus on fentanyl in females: Sex and gender differences in the physiological and behavioral effects of fentanyl. Frontiers in Neuroendocrinology 71, pages 101096.
Crossref
Crossref
Zishan Cui, Alexa Norton & Mohammad Karamouzian. (2023) Characterizing Methamphetamine Use Among People Who Use Opioids: A Systematic Review. International Journal of Mental Health and Addiction.
Crossref
Crossref
JoAnn Petrie, Logan R. Kowallis, Sarah Kamhout, Kyle B. Bills, Daniel Adams, Donovan E. Fleming, Bruce L. Brown & Scott C. Steffensen. (2023) Gender-Specific Interactions in a Visual Object Recognition Task in Persons with Opioid Use Disorder. Biomedicines 11:9, pages 2460.
Crossref
Crossref
Teresa López-Arteaga, Moreno-Rubio Carlos & Mohedano Moriano Alicia. (2023) Risk factors for opioid addiction in chronic non-cancer pain. Heliyon, pages e19707.
Crossref
Crossref
Gabriela Rolová, Desiree Eide, Roman Gabrhelík, Ingvild Odsbu, Thomas Clausen & Svetlana Skurtveit. (2023) Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway. Substance Abuse Treatment, Prevention, and Policy 18:1.
Crossref
Crossref
Adeolu Funso Oladunjoye, Crystal Obi-Azuike, Funmilola Babalola, Gibson Anugwom, Henry Onyeaka, Kammarauche Aneni & Eduardo D. Espiridion. (2023) Major Depressive Disorder prolongs hospital stay among hospitalizations with Opioid Use Disorder. Psychiatry Research Communications 3:2, pages 100118.
Crossref
Crossref
Renata C.N. Marchette, Erika R. Carlson, Emma V. Frye, Lyndsay E. Hastings, Janaina C.M. Vendruscolo, Gustavo Mejias-Torres, Stephen J. Lewis, Aidan Hampson, Nora D. Volkow, Leandro F. Vendruscolo & George F. Koob. (2023) Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences. Journal of Pharmacology and Experimental Therapeutics 385:2, pages 117-134.
Crossref
Crossref
Jessica M. Illenberger, Francisco J. Flores-Ramirez, Alessandra Matzeu, Barbara J. Mason & Rémi Martin-Fardon. (2023) Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats. Frontiers in Pharmacology 14.
Crossref
Crossref
Mary Tresa Zanda, Gabriele Floris & Stephanie E. Sillivan. (2023) Orbitofrontal cortex microRNAs support long-lasting heroin seeking behavior in male rats. Translational Psychiatry 13:1.
Crossref
Crossref
Alexa A. Lopez, Anne E. Dressel, Emily Deal, Emma Krueger, Maria Graf, Belinda Pittman, Marin Schmitt, Peninnah Kako, Brittany Ochoa-Nordstrum & Lucy Mkandawire-Valhmu. (2023) Substance Misuse Themes Among Women Living in Transitional Housing. Journal of Addictions Nursing 34:2, pages 121-130.
Crossref
Crossref
Catherine Baxley, Brian Borsari, Jill V. Reavis, Jennifer K. Manuel, Ellen Herbst, William Becker, David Pennington, Steven L. Batki & Karen Seal. (2023) Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials. Addictive Behaviors 139, pages 107589.
Crossref
Crossref
Natasha Yvonne Hall, Long Le, Julie Abimanyi-Ochom, Maree Teesson & Cathy Mihalopoulos. (2023) Identifying the most common barriers to opioid agonist treatment in an Australian setting. Australian Journal of Primary Health 29:5, pages 445-454.
Crossref
Crossref
Cynthia A. Crawford, Jordan A. Taylor, Ginny I. Park, Jasmine W. Rios, Joseph Bunch, Constance J. Greenwood, David Y. Lopez Sanchez & Diego J. Gonzales. (2023) Effects of neonatal fentanyl on late adolescent opioid-mediated behavior. Frontiers in Neuroscience 17.
Crossref
Crossref
Òscar Miró, Guillermo Burillo-Putze, Yasmin Schmid, Emilio Salgado, Matthias E. Liechti, Alison M. Dines, Isabelle Giraudon, Fridtjof Heyerdahl, Knut Erik Hovda, Odd Martin Vallersne, Florian Eyer, David M. Wood, Christopher Yates, Paul I. Dargan & Miguel Galicia. (2022) Severity of emergency department presentations due to acute drug toxicity in Europe: a longitudinal analysis over a 6-year period (2014–2019) stratified by sex. European Journal of Emergency Medicine 30:1, pages 21-31.
Crossref
Crossref
Shveta V. Parekh, Lydia O. Adams, Gillian A. Barkell & Donald T. Lysle. (2023) Sex-differences in anxiety, neuroinflammatory markers, and enhanced fear learning following chronic heroin withdrawal. Psychopharmacology 240:2, pages 347-359.
Crossref
Crossref
Eleanor Blair Towers, Madison Kilgore, Anousheh Bakhti-Suroosh, Lasyapriya Pidaparthi, Ivy L. Williams, Jean M. Abel & Wendy J. Lynch. (2023) Sex differences in the neuroadaptations associated with incubated cocaine-craving: A focus on the dorsomedial prefrontal cortex. Frontiers in Behavioral Neuroscience 16.
Crossref
Crossref
George F. Koob, Michael A. Arends, Mandy Mccracken & Michel Le Moal. 2023. Opioids. Opioids
1
400
.
Layla Edwards, Sacha Kendall Jamieson, Julia Bowman, Sungwon Chang, Josie Newton & Elizabeth Sullivan. (2022) A systematic review of post-release programs for women exiting prison with substance-use disorders: assessing current programs and weighing the evidence. Health & Justice 10:1.
Crossref
Crossref
Gladys E. Ibañez, Mariana Sanchez, Karina Villalba & Hortensia Amaro. (2022) Acting with awareness moderates the association between lifetime exposure to interpersonal traumatic events and craving via trauma symptoms: a moderated indirect effects model. BMC Psychiatry 22:1.
Crossref
Crossref
Jordan M. BraciszewskiAbisola E. IduBobbi Jo H. YarboroughScott P. StumboJennifer F. BobbKatharine A. BradleyRebecca C. RossomMark T. MurphyIngrid A. BinswangerCynthia I. CampbellJoseph E. GlassTheresa E. MatsonGwen T. LaphamAmy M. LoreeCelestina Barbosa-LeikerMary A. HatchJudith I. TsuiJulia H. ArnstenAngela StottsViviana HorigianRebecca HutchesonGavin BartAndrew J. SaxonManu ThakralDeborah Ling GrantChaya Mangel PflugeisenIngrid UsagaLawrence T. MadziwaAngela SilvaDenise M. Boudreau. (2022) Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder. Psychiatric Services 73:12, pages 1330-1337.
Crossref
Crossref
Melissa C. Knouse, Anna G. McGrath, Andre U. Deutschmann, Matthew T. Rich, Lia J. Zallar, Anjali M. Rajadhyaksha & Lisa A. Briand. (2022) Sex differences in the medial prefrontal cortical glutamate system. Biology of Sex Differences 13:1.
Crossref
Crossref
Tara Mariolis, Amanda Wilson & Lisa M. Chiodo. (2022) The Impact of Individual Counseling on Treatment for Opioid Use. Journal of Addictions Nursing 33:4, pages 271-279.
Crossref
Crossref
Angela Di Paola, Noor Taweh, Breanne E. Biondi, Ariadna Forray, Cynthia A. Frank, Albert Shaw & Sandra A. Springer. (2022) Gender differences among persons entering medication treatment for opioid use disorder in the community. The American Journal on Addictions 31:5, pages 390-395.
Crossref
Crossref
Tiffany Love, Andrey A. Shabalin, Rachel L. Kember, Anna R. Docherty, Hang Zhou, Vincent Koppelmans, Joel Gelernter, Anne K. Baker, Emily Hartwell, Jacob Dubroff, Jon-Kar Zubieta & Henry R. Kranzler. (2022) Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function. Neuropsychopharmacology 47:10, pages 1784-1790.
Crossref
Crossref
Michael M. Morgan & Kristin Ataras. (2022) Sex differences in the impact of pain, morphine administration and morphine withdrawal on quality of life in rats. Pharmacology Biochemistry and Behavior 219, pages 173451.
Crossref
Crossref
Rajshri Bolson, Andy Lalka, Hannah Korrell, Sarah E. Sibbel & Karsten Bartels. (2022) Shared Decision-Making Tool for Opioid Prescribing After Ambulatory Orthopedic Surgery in Veterans: A Randomized Controlled Clinical Trial. Journal of Hand Surgery Global Online 4:4, pages 196-200.
Crossref
Crossref
Lauren A. Walter, Savannah Bunnell, Kathryn Wiesendanger & Alyson J. McGregor. (2022) Sex, gender, and the opioid epidemic: Crucial implications for acute care. AEM Education and Training 6:S1.
Crossref
Crossref
Mirabela Romanescu, Valentina Buda, Adelina Lombrea, Minodora Andor, Ionut Ledeti, Maria Suciu, Corina Danciu, Cristina Adriana Dehelean & Liana Dehelean. (2022) Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review. Journal of Personalized Medicine 12:6, pages 907.
Crossref
Crossref
Breanne E. Biondi, Brad J. Anderson, Kristina T. Phillips & Michael Stein. (2022) Sex Differences in Injection Drug Risk Behaviors Among Hospitalized Persons. Journal of Addiction Medicine 16:3, pages e165-e170.
Crossref
Crossref
Taeho Greg Rhee & Robert A. Rosenheck. (2022) Gender Differences in Psychiatric and Behavioral Health Burden Among Adults With Alcohol and Other Substance Use Disorders in the United States. Journal of Addiction Medicine 16:3, pages 295-302.
Crossref
Crossref
Monica Rivera Mindt, Kelly Coulehan, Maral Aghvinian, Travis M. Scott, James Patrick Olsen, Chinazo O. Cunningham, Franchesca Arias & Julia H. Arnsten. (2022) Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment. Journal of Substance Abuse Treatment 135, pages 108644.
Crossref
Crossref
Shannon N. Ogden, Melissa E. Dichter & Angela R. Bazzi. (2022) Intimate partner violence as a predictor of substance use outcomes among women: A systematic review. Addictive Behaviors 127, pages 107214.
Crossref
Crossref
Eleanor Blair Towers, Ben Setaro & Wendy J. Lynch. (2022) Sex- and Dose-Dependent Differences in the Development of an Addiction-Like Phenotype Following Extended-Access Fentanyl Self-Administration. Frontiers in Pharmacology 13.
Crossref
Crossref
Jessica L. Sharp, Tallia Pearson & Mark A. Smith. (2022) Sex differences in opioid receptor mediated effects: Role of androgens. Neuroscience & Biobehavioral Reviews 134, pages 104522.
Crossref
Crossref
Anna Beth Parlier-Ahmad, Maja Radic, Dace S. Svikis & Caitlin E. Martin. (2022) Short communication: Relationship between social determinants and opioid use disorder treatment outcomes by gender. Drug and Alcohol Dependence 232, pages 109337.
Crossref
Crossref
Celeste Seger, Michelle Tuten, Carla L. Storr & John M. Majer. (2022) Delivery Outcomes Among Pregnant Women With Comorbid Psychiatric and Substance Use Disorders Receiving Comprehensive Treatment. Journal of the American Psychiatric Nurses Association, pages 107839032210793.
Crossref
Crossref
Britton Gibson, Emily Hoff, Alissa Haas, Zoe M Adams, Carolina R Price, Dawn Goddard-Eckrich, Sangini S Sheth, Anindita Dasgupta & Jaimie P Meyer. (2022) Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders. Women's Health 18, pages 174550652110705.
Crossref
Crossref
Céline Nicolas, Natalie E. Zlebnik, Mehdi Farokhnia, Lorenzo Leggio, Satoshi Ikemoto & Yavin Shaham. (2022) Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review. Pharmacological Reviews 74:1, pages 119-140.
Crossref
Crossref
Colleen R. Freund, Stefanie M. VanDuine & Jennifer L. Cullen. (2022) Opioid Prescription Trends in a US Dental School Clinic, 2014-2018: A Retrospective Study Using Electronic Health Record Data. Journal of Public Health Management and Practice 28:1, pages E264-E272.
Crossref
Crossref
Conchita Gomez & Michel-Henri Delcroix. (2022) Les conduites addictives au féminin. Sages-Femmes 21:1, pages 12-14.
Crossref
Crossref
Miriam T.H. Harris, Jordana Laks, Natalie Stahl, Sarah M. Bagley, Kelley Saia & Wendee M. Wechsberg. (2022) Gender Dynamics in Substance Use and Treatment. Medical Clinics of North America 106:1, pages 219-234.
Crossref
Crossref
Tolulope Olupona & Olaniyi Olayinka. 2022. Substance and Non-Substance Related Addictions. Substance and Non-Substance Related Addictions
141
145
.
Marian Jarlenski & Elizabeth E. Krans. (2021) Co-occurring Substance Use Disorders Identified Among Delivery Hospitalizations in the United States. Journal of Addiction Medicine 15:6, pages 504-507.
Crossref
Crossref
Eleanor Blair Towers & Wendy J. Lynch. (2021) The importance of examining sex differences in animal models validated to induce an addiction-like phenotype. Pharmacology Biochemistry and Behavior 209, pages 173255.
Crossref
Crossref
Sara Rodríguez-Espinosa, Ainhoa Coloma-Carmona, Ana Pérez-Carbonell, José F. Román-Quiles & José L. Carballo. (2021) Clinical and psychological factors associated with interdose opioid withdrawal in chronic pain population. Journal of Substance Abuse Treatment 129, pages 108386.
Crossref
Crossref
Melissa C. Knouse & Lisa A. Briand. (2021) Behavioral sex differences in cocaine and opioid use disorders: The role of gonadal hormones. Neuroscience & Biobehavioral Reviews 128, pages 358-366.
Crossref
Crossref
Jordan P. Davis, David Eddie, John Prindle, Emily R. Dworkin, Nina C. Christie, Shaddy Saba, Graham T. DiGuiseppi, John D. Clapp & John F. Kelly. (2021) Sex differences in factors predicting post‐treatment opioid use. Addiction 116:8, pages 2116-2126.
Crossref
Crossref
Eleanor Blair Towers, Anousheh Bakhti-Suroosh & Wendy J. Lynch. (2021) Females develop features of an addiction-like phenotype sooner during withdrawal than males. Psychopharmacology 238:8, pages 2213-2224.
Crossref
Crossref
Miriam T.H. Harris, Sarah M. Bagley, Ariel Maschke, Samantha F. Schoenberger, Spoorthi Sampath, Alexander Y. Walley & Christine M. Gunn. (2021) Competing risks of women and men who use fentanyl: “The number one thing I worry about would be my safety and number two would be overdose”. Journal of Substance Abuse Treatment 125, pages 108313.
Crossref
Crossref
Iraia Muñoa-Hoyos, Manu Araolaza, Itziar Urizar-Arenaza, Marta Gianzo, Jon Irazusta & Nerea Subiran. (2021) Sex dependent alteration of epigenetic marks after chronic morphine treatment in mice organs. Food and Chemical Toxicology 152, pages 112200.
Crossref
Crossref
Casper J. H. Wolf, Harmen Beurmanjer, Boukje A. G. Dijkstra, Alexander C. Geerlings, Marcia Spoelder, Judith R. Homberg & Arnt F. A. Schellekens. (2021) Characterization of the GHB Withdrawal Syndrome. Journal of Clinical Medicine 10:11, pages 2333.
Crossref
Crossref
Caroline B. Pantazis, Luis A. GonzalezBrendan J. Tunstall, Stephanie A. Carmack, George F. KoobLeandro F. Vendruscolo. (2021) Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction. Science Advances 7:15.
Crossref
Crossref
Jacqueline A. Quigley & Jill B. Becker. (2021) Activation of G-protein coupled estradiol receptor 1 in the dorsolateral striatum attenuates preference for cocaine and saccharin in male but not female rats. Hormones and Behavior 130, pages 104949.
Crossref
Crossref
Anousheh Bakhti-Suroosh, Eleanor Blair Towers & Wendy J. Lynch. (2021) A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse. Psychopharmacology 238:4, pages 1029-1046.
Crossref
Crossref
Mohit Kumar, Jennifer R. Rainville, Kori Williams, Joshua A. Lile, Georgia E. Hodes, Fair M. Vassoler & Jill R. Turner. (2021) Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal. Neuropharmacology 186, pages 108469.
Crossref
Crossref
Maria A. Corcorran, Judith I. Tsui, John D. Scott, Julia C. Dombrowski & Sara N. Glick. (2021) Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington. Drug and Alcohol Dependence 220, pages 108525.
Crossref
Crossref
Mónica L. Caudillo & Andrés Villarreal. (2021) The Opioid Epidemic and Nonmarital Childbearing in the United States, 2000–2016. Demography 58:1, pages 345-378.
Crossref
Crossref
Teddy G. Goetz, Jill B. Becker & Carolyn M. Mazure. (2021) Women, opioid use and addiction. The FASEB Journal 35:2.
Crossref
Crossref
Christine LaGrotta. (2021) Gender Differences in Addiction. Current Addiction Reports 8:1, pages 64-70.
Crossref
Crossref
Roxana Geoffrion, Emily C. Yang, Nicole A. Koenig, Lori A. Brotto, Alasdair M. Barr, Terry Lee, Catherine Allaire, Mohamed A. Bedaiwy & Paul J. Yong. (2021) Recreational Cannabis Use Before and After Legalization in Women With Pelvic Pain. Obstetrics & Gynecology 137:1, pages 91-99.
Crossref
Crossref
Caitlin E. Martin, Anna Scialli & Mishka Terplan. 2021. How Sex and Gender Impact Clinical Practice. How Sex and Gender Impact Clinical Practice
23
51
.
Jacob Daheim, Shin Ye Kim, Ashley Neduvelil & Nguyen P Nguyen. (2020) Men, Chronic Pain, and Prescription Pain Medication Use: The Role of Gender Role Beliefs in a Longitudinal Moderated Mediation Model. Pain Medicine 21:12, pages 3603-3614.
Crossref
Crossref
Zahra Boroumandfar, Masoud Kianpour & Maryam Afshari. (2020) Ups and downs of drug rehab among women: a qualitative study. BMC Women's Health 20:1.
Crossref
Crossref
Ethan MorganBrian A. FeinsteinChristina Dyar. (2020) Disparities in Prescription Opioid Misuse Affecting Sexual Minority Adults Are Attenuated by Depression and Suicidal Ideation. LGBT Health 7:8, pages 431-438.
Crossref
Crossref
Hannah D. Fulenwider, Sadie E. Nennig, Hiba Hafeez, Michaela E. Price, Federico Baruffaldi, Marco Pravetoni, Kejun Cheng, Kenner C. Rice, Daniel F. Manvich & Jesse R. Schank. (2019) Sex differences in oral oxycodone self‐administration and stress‐primed reinstatement in rats. Addiction Biology 25:6.
Crossref
Crossref
Taeho Greg Rhee, MacKenzie R. Peltier, Mehmet Sofuoglu & Robert A. Rosenheck. (2020) Do Sex Differences Among Adults With Opioid Use Disorder Reflect Sex-specific Vulnerabilities? A Study of Behavioral Health Comorbidities, Pain, and Quality of Life. Journal of Addiction Medicine 14:6, pages 502-509.
Crossref
Crossref
Jessica Y. Ho. (2020) Cycles of Gender Convergence and Divergence in Drug Overdose Mortality. Population and Development Review 46:3, pages 443-470.
Crossref
Crossref
Natalie M. Lopresti, Manuel Esguerra & Paul G. Mermelstein. (2020) Sex Differences in Animal Models of Opioid Reward. Current Sexual Health Reports 12:3, pages 186-194.
Crossref
Crossref
K. Moussawi, M. M. Ortiz, S. C. Gantz, B. J. Tunstall, R. C. N. Marchette, A. BonciG. F. KoobL. F. Vendruscolo. (2020) Fentanyl vapor self-administration model in mice to study opioid addiction. Science Advances 6:32.
Crossref
Crossref
Andreas Pikwer, Madeleine Carlsson, Duraid Abod Mahmoud & Markus Castegren. (2020) The Patient’s Gender Influencing the Accuracy of Diagnosis and Proposed Sepsis Treatment in Constructed Cases. Emergency Medicine International 2020, pages 1-7.
Crossref
Crossref
Jennifer A. Ross & Elisabeth J. Van Bockstaele. (2020) The role of catecholamines in modulating responses to stress: Sex‐specific patterns, implications, and therapeutic potential for post‐traumatic stress disorder and opiate withdrawal. European Journal of Neuroscience 52:1, pages 2429-2465.
Crossref
Crossref
Francesco Traccis, Roberto Frau & Miriam Melis. (2020) Gender Differences in the Outcome of Offspring Prenatally Exposed to Drugs of Abuse. Frontiers in Behavioral Neuroscience 14.
Crossref
Crossref
Kimberly J. Templeton. (2020) Sex and Gender Issues in Pain Management. Journal of Bone and Joint Surgery 102:Suppl 1, pages 32-35.
Crossref
Crossref
Adam Kimbrough, Jenni Kononoff, Sierra Simpson, Marsida Kallupi, Sharona Sedighim, Kenia Palomino, Dana Conlisk, Jeremiah D. Momper, Giordano de Guglielmo & Olivier George. (2020) Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats. Psychopharmacology 237:5, pages 1545-1555.
Crossref
Crossref
Christopher M. Jones, Natasha Underwood & Wilson M. Compton. (2019) Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17. Addiction 115:2, pages 347-353.
Crossref
Crossref
Jennifer K. Bello, Catherine Hearing, Joanne Salas, Jeremiah Weinstock & Donald Linhorst. (2019) Trends in Substance Use by Gender Among Participants in a Jail‐Based Substance Use Disorder Treatment Program: 1998–2016. Journal of Forensic Sciences 65:1, pages 97-102.
Crossref
Crossref
Maribel Vazquez, Jessica H. Frazier, Carmela M. Reichel & Jamie Peters. (2019) Acute ovarian hormone treatment in freely cycling female rats regulates distinct aspects of heroin seeking. Learning & Memory 27:1, pages 6-11.
Crossref
Crossref
Kimberly Goodyear & Carolina L. Haass-Koffler. (2019) Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations. Neurotherapeutics 17:1, pages 100-104.
Crossref
Crossref
Monica A. Tincopa, Brooke Kenney, Elliot B. Tapper, Pratima Sharma, Shari Rogal, Jessica Mellinger, Sameer D. Saini, Brahmajee K. Nallamothu, Amit G. Singal & Akbar K. Waljee. (2020) Prescription opioid use is common and associated with worse clinical outcomes in individuals with chronic liver disease. GastroHep 2:1, pages 13-21.
Crossref
Crossref
Victoria Lykke Syse, Mette Brekke, Marit Mæhle Grimsrud, Per Sverre Persett, Fridtjof Heyerdahl, Knut Erik Hovda & Odd Martin Vallersnes. (2019) Gender differences in acute recreational drug toxicity: a case series from Oslo, Norway. BMC Emergency Medicine 19:1.
Crossref
Crossref
Javad Mohammadian & Hossein Miladi-Gorji. (2019) Age- and sex-related changes in the severity of physical and psychological dependence in morphine-dependent rats. Pharmacology Biochemistry and Behavior 187, pages 172793.
Crossref
Crossref
Mirsada Serdarevic, Catherine W. Striley, Kelly K. Gurka, Robert F. Leeman & Linda B. Cottler. (2019) Sex differences in prescription opioid use patterns assessed through a community engagement program in Florida. Drug and Alcohol Dependence 204, pages 107568.
Crossref
Crossref
Hui G. Cheng, Maria A. Parker & James C. Anthony. (2019) Female-male differences in prescription pain reliever dependence levels: Evidence on newly incident adolescent and young adult users in the United States, 2002–2014. Drug and Alcohol Dependence 204, pages 107466.
Crossref
Crossref
Daniel J. Paulus, Andrew H. Rogers, Jafar Bakhshaie, Kevin E. Vowles & Michael J. Zvolensky. (2019) Pain severity and prescription opioid misuse among individuals with chronic pain: The moderating role of alcohol use severity. Drug and Alcohol Dependence 204, pages 107456.
Crossref
Crossref
Andrew S Huhn, D Andrew Tompkins, Claudia M Campbell & Kelly E Dunn. (2019) Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal. Pain Medicine 20:10, pages 1942-1947.
Crossref
Crossref
Teresa Rojas Rojas, Vincent Di Beo, Jessica Delorme, Tangui Barre, Philippe Mathurin, Camelia Protopopescu, François Bailly, Marion Coste, Nicolas Authier, Maria Patrizia Carrieri, Benjamin Rolland & Fabienne Marcellin. (2019) Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project. International Journal of Drug Policy 72, pages 61-68.
Crossref
Crossref
Andrew S. Huhn, Meredith S. Berry & Kelly E. Dunn. (2019) Review: Sex‐Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder. The American Journal on Addictions 28:4, pages 246-261.
Crossref
Crossref
Lorenzo Zamboni, Anna Franceschini, Igor Portoghese, Laura Morbioli & Fabio Lugoboni. (2019) Sexual Functioning and Opioid Maintenance Treatment in Women. Results From a Large Multicentre Study. Frontiers in Behavioral Neuroscience 13.
Crossref
Crossref
Amanda K. Gilmore, Constance Guille, Nathaniel L. Baker, Kathleen T. Brady, Christine K. Hahn, Callah M. Davis, Jenna L. McCauley & Sudie E. Back. (2019) Gender differences in subjective stress and neuroendocrine response to a stress task among individuals with opioid dependence: A pilot study. Addictive Behaviors 92, pages 148-154.
Crossref
Crossref
Monica A Konerman, Mary Rogers, Brooke Kenney, Amit G Singal, Elliot Tapper, Pratima Sharma, Sameer Saini, Brahmajee Nallamothu & Akbar Waljee. (2019) Opioid and benzodiazepine prescription among patients with cirrhosis compared to other forms of chronic disease. BMJ Open Gastroenterology 6:1, pages e000271.
Crossref
Crossref
Sara Ling, Remar Mangaoil, Kristin Cleverley, Beth Sproule & Martine Puts. (2019) A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions. Drug and Alcohol Dependence 197, pages 168-182.
Crossref
Crossref
M. Islam & Dennis Wollersheim. (2019) Who Are Dispensed the Bulk Amount of Prescription Opioids?. Journal of Clinical Medicine 8:3, pages 293.
Crossref
Crossref
Nicole M. Enman, Beverly A.S. Reyes, Yufan Shi, Rita J. Valentino & Elisabeth J. Van Bockstaele. (2019) Sex differences in morphine-induced trafficking of mu-opioid and corticotropin-releasing factor receptors in locus coeruleus neurons. Brain Research 1706, pages 75-85.
Crossref
Crossref
Ainhoa Coloma-Carmona, José L. Carballo, Jesús Rodríguez-Marín & Ana Pérez-Carbonell. (2019) Withdrawal symptoms predict prescription opioid dependence in chronic pain patients. Drug and Alcohol Dependence 195, pages 27-32.
Crossref
Crossref
Ainhoa Coloma‐Carmona, José Luis Carballo, Jesús Rodríguez‐Marín & Carlos Javier van‐der Hofstadt. (2018) The Adjective Rating Scale for Withdrawal: Validation of its ability to assess severity of prescription opioid misuse. European Journal of Pain 23:2, pages 307-315.
Crossref
Crossref
Alicja Lerner & Michael Klein. (2019) Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development. Brain Communications 1:1.
Crossref
Crossref
K. Paul Rezai-Zadeh, Richard N. Engstrom, Andy Sharma, Yiming Chen, Jun Chu, Robin Parker Cox & Mei-Ling Ting Lee. (2019) Generational trends and patterns in readmission within a statewide cohort of clients receiving heroin use disorder treatment in Maryland, 2007–2013. Journal of Substance Abuse Treatment 96, pages 82-91.
Crossref
Crossref
M Mofizul Islam, Ian S. McRae, Soumya Mazumdar, Paul Simpson, Dennis Wollersheim, Kaniz Fatema & Tony Butler. (2018) Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation. BMC Pharmacology and Toxicology 19:1.
Crossref
Crossref
Daniel I Rhon, Suzanne J Snodgrass, Joshua A Cleland, Charles D Sissel & Chad E Cook. (2018) Predictors of chronic prescription opioid use after orthopedic surgery: derivation of a clinical prediction rule.. Perioperative Medicine 7:1.
Crossref
Crossref
M Islam & Dennis Wollersheim. (2018) Variation in Prescription Opioid Dispensing across Neighborhoods of Diverse Socioeconomic Disadvantages in Victoria, Australia. Pharmaceuticals 11:4, pages 116.
Crossref
Crossref
Chaya Possick & Michal Itzick. (2018) Women’s Experience of Drug Abuse Treatment in a Mixed-Gender Therapeutic Community. Affilia 33:4, pages 493-508.
Crossref
Crossref
Suzanne Nielsen, Nicholas Lintzeris, Bridin Murnion, Louisa Degenhardt, Raimondo Bruno, Paul Haber, Jennifer Johnson, Mark Hardy, Stephen Ling, Craig Saddler, Adrian Dunlop, Apo Demirkol, Catherine Silsbury, Nghi Phung, Jennie Houseman & Briony Larance. (2018) Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence. Drug and Alcohol Review 37:7, pages 887-896.
Crossref
Crossref
Emily L. Newman, Michael Z. Leonard, Danielle T. Arena, Rosa M.M. de Almeida & Klaus A. Miczek. (2018) Social defeat stress and escalation of cocaine and alcohol consumption: Focus on CRF. Neurobiology of Stress 9, pages 151-165.
Crossref
Crossref
Kristen E. Pleil & Mary Jane Skelly. (2018) CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety. Alcohol 72, pages 33-47.
Crossref
Crossref
Aimee N. C. Campbell, Celestina Barbosa-Leiker, Mary Hatch-Maillette, Sarah E. Mennenga, Martina Pavlicova, Jennifer Scodes, Tanya Saraiya, Shannon G. Mitchell, John Rotrosen, Patricia Novo, Edward V. Nunes & Shelly F. Greenfield. (2018) Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial. The American Journal on Addictions 27:6, pages 465-470.
Crossref
Crossref
Paolo Mannelli, Marvin Swartz & Li-Tzy Wu. (2018) Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone. The American Journal on Addictions 27:6, pages 471-476.
Crossref
Crossref
Amanda K. Gilmore, Jennifer L. Jones, Angela D. Moreland, Christine K. Hahn, Kathleen T. Brady & Sudie E. Back. (2018) Gender moderates the association between distress tolerance and alcohol use among individuals with opioid use disorder. Drug and Alcohol Dependence 190, pages 9-12.
Crossref
Crossref
Milen L. Radell, Michael Todd Allen, Belinda Favaloro, Catherine E. Myers, Paul Haber, Kirsten Morley & Ahmed A. Moustafa. (2018) Intolerance of uncertainty and conditioned place preference in opioid addiction. PeerJ 6, pages e4775.
Crossref
Crossref
Anthony L. Riley, Briana J. Hempel & Matthew M. Clasen. (2018) Sex as a biological variable: Drug use and abuse. Physiology & Behavior 187, pages 79-96.
Crossref
Crossref
Chang-Chih Tsou, Pei-Shen Ho, Chun-Long Lin & San-Yuan Huang. (2018) Lack of association between NeuroD1/D6 gene polymorphism and heroin dependence in Han-chinese male population. Journal of Medical Sciences 38:5, pages 228.
Crossref
Crossref
Laura Zielinski, Meha Bhatt, Nitika Sanger, Carolyn Plater, Andrew Worster, Michael Varenbut, Jeff Daiter, Guillaume Pare, David C. Marsh, Dipika Desai, James MacKillop, Meir Steiner, Stephanie McDermid Vaz, Lehana Thabane & Zainab Samaan. (2017) Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences. Biology of Sex Differences 8:1.
Crossref
Crossref
Samantha M. Pruden & Angela Starkweather. (2017) Prescription Opioid Abuse and Addiction: How Can We Curb the Trends?. Topics in Pain Management 33:5, pages 1-7.
Crossref
Crossref
Alexandra M. Franklyn, Joseph K. Eibl, Graham J. Gauthier & David C. Marsh. (2017) The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada. PLOS ONE 12:11, pages e0187633.
Crossref
Crossref
Akiko Shimamoto & Virginie Rappeneau. (2017) Sex-dependent mental illnesses and mitochondria. Schizophrenia Research 187, pages 38-46.
Crossref
Crossref
Beniamino Leone, Marco Di Nicola, Lorenzo Moccia, Mauro Pettorruso, Luisa De Risio, Giuseppe Nucara, Lorenzo Zamboni, Antonino Callea, Luigi Janiri, Mauro Cibin & Fabio Lugoboni. (2017) Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services. Addictive Behaviors 71, pages 107-110.
Crossref
Crossref
Herminio M Guajardo, Kevin Snyder, Andrew Ho & Rita J Valentino. (2016) Sex Differences in μ-Opioid Receptor Regulation of the Rat Locus Coeruleus and Their Cognitive Consequences. Neuropsychopharmacology 42:6, pages 1295-1304.
Crossref
Crossref
Angelo G. I. Maremmani, Pier Paolo Pani, Luca Rovai, Silvia Bacciardi & Icro Maremmani. (2017) Toward the Identification of a Specific Psychopathology of Substance Use Disorders. Frontiers in Psychiatry 8.
Crossref
Crossref
Katherine R. MarksCarl G. Leukefeld. (2017) A Preliminary Study Examining Women's Physical Health and Nonmedical Prescription Opioid Use in a Recovering Framework. Journal of Women's Health 26:3, pages 286-293.
Crossref
Crossref
Liana Fattore & Miriam Melis. (2016) Sex differences in impulsive and compulsive behaviors: a focus on drug addiction. Addiction Biology 21:5, pages 1043-1051.
Crossref
Crossref
Devon Collins, Brian Reed, Yong Zhang & Mary Jeanne Kreek. (2016) Sex differences in responsiveness to the prescription opioid oxycodone in mice. Pharmacology Biochemistry and Behavior 148, pages 99-105.
Crossref
Crossref
Laia Rodríguez-Cintas, Constanza Daigre, Lara Grau-López, Carmen Barral, Jesús Pérez-Pazos, Núria Voltes, María Dolores Braquehais, Miquel Casas & Carlos Roncero. (2016) Impulsivity and addiction severity in cocaine and opioid dependent patients. Addictive Behaviors 58, pages 104-109.
Crossref
Crossref
Manuela Graziani & Robert Nisticò. (2016) Gender difference in prescription opioid abuse: A focus on oxycodone and hydrocodone. Pharmacological Research 108, pages 31-38.
Crossref
Crossref
Pier P. Pani, Angelo G. I. Maremmani, Emanuela Trogu, Federica Vigna-Taglianti, Federica Mathis, Roberto Diecidue, Ursula Kirchmayer, Laura Amato, Marina Davoli, Joli Ghibaudi, Antonella Camposeragna, Alessio Saponaro, Fabrizio Faggiano & Icro Maremmani. (2016) Psychic Structure of Opioid Addiction. Addictive Disorders & Their Treatment 15:1, pages 6-16.
Crossref
Crossref
Eric L. Garland, Samantha M. Brown & Matthew O. Howard. (2015) Thought suppression as a mediator of the association between depressed mood and prescription opioid craving among chronic pain patients. Journal of Behavioral Medicine 39:1, pages 128-138.
Crossref
Crossref
Uros Rakita, Peter Giacobbe & Chris Cavacuiti. (2016) Opioid use disorder patients’ perceptions of healthcare delivery platforms. SAGE Open Medicine 4, pages 205031211667040.
Crossref
Crossref
Maja Djurendic-Brenesel & Vladimir Pilija. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
922
932
.
Stacey Gramann. 2016. Treating Comorbid Opioid Use Disorder in Chronic Pain. Treating Comorbid Opioid Use Disorder in Chronic Pain
89
101
.
Jacqueline M. Barker, Jane R. Taylor, Taco J. De Vries & Jamie Peters. (2015) Brain-derived neurotrophic factor and addiction: Pathological versus therapeutic effects on drug seeking. Brain Research 1628, pages 68-81.
Crossref
Crossref
Bradley T. Kerridge, Tulshi D. Saha, S. Patricia Chou, Haitao Zhang, Jeesun Jung, W. June Ruan, Sharon M. Smith, Boji Huang & Deborah S. Hasin. (2015) Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions – III. Drug and Alcohol Dependence 156, pages 47-56.
Crossref
Crossref
Liana Fattore. (2015) Reward processing and drug addiction: does sex matter?. Frontiers in Neuroscience 9.
Crossref
Crossref
Paxton Bach, M-J Milloy, Paul Nguyen, John Koehn, Silvia Guillemi, Thomas Kerr & Evan Wood. (2015) Gender differences in access to methadone maintenance therapy in a Canadian setting. Drug and Alcohol Review 34:5, pages 503-507.
Crossref
Crossref
Kimberly Page, Judith Tsui, Lisa Maher, Kachit Choopanya, Suphak Vanichseni, Philip A. Mock, Connie Celum & Michael Martin. (2015) Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs. JAIDS Journal of Acquired Immune Deficiency Syndromes 69:Supplement 2, pages S169-S175.
Crossref
Crossref
Jonathan J.K. Stoltman, Eric A. Woodcock, Jamey J. Lister, Mark K. Greenwald & Leslie H. Lundahl. (2015) Exploration of the telescoping effect among not-in-treatment, intensive heroin-using research volunteers. Drug and Alcohol Dependence 148, pages 217-220.
Crossref
Crossref
Jeanne Manubay, Jesse Davidson, Suzanne Vosburg, Jermaine Jones, Sandra Comer & Maria Sullivan. (2015) Sex Differences Among Opioid-Abusing Patients With Chronic Pain in a Clinical Trial. Journal of Addiction Medicine 9:1, pages 46-52.
Crossref
Crossref
Caroline Davis & Liana Fattore. 2015. Cannabinoid Modulation of Emotion, Memory, and Motivation. Cannabinoid Modulation of Emotion, Memory, and Motivation
283
325
.
Pier Paolo Pani, Emanuela Trogu, Federica Vigna-Taglianti, Federica Mathis, Roberto Diecidue, Ursula Kirchmayer, Laura Amato, Marina Davoli, Joli Ghibaudi, Antonella Camposeragna, Alessio Saponaro, Fabrizio Faggiano, Angelo Giovanni Icro Maremmani & Icro Maremmani. (2014) Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment. Annals of General Psychiatry 13:1.
Crossref
Crossref
Monica Bawor, Brittany B Dennis, Rebecca Anglin, Meir Steiner, Lehana Thabane & Zainab Samaan. (2014) Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol. Systematic Reviews 3:1.
Crossref
Crossref
Linn Gjersing & Anne Line Bretteville-Jensen. (2014) Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users. BMC Public Health 14:1.
Crossref
Crossref
Esther K. Choo, Carole Douriez & Traci Green. (2014) Gender and Prescription Opioid Misuse in the Emergency Department. Academic Emergency Medicine 21:12, pages 1493-1498.
Crossref
Crossref
Paul I. MuseyJr.Jr., Sarah D. Linnstaedt, Timothy F. Platts-Mills, James R. Miner, Andrey V. Bortsov, Basmah Safdar, Polly Bijur, Alex Rosenau, Daniel S. Tsze, Andrew K. Chang, Suprina Dorai, Kirsten G. Engel, James A. Feldman, Angela M. Fusaro, David C. Lee, Mark Rosenberg, Francis J. Keefe, David A. Peak, Catherine S. Nam, Roma G. Patel, Roger B. Fillingim & Samuel A. McLean. (2014)
Gender Differences in Acute and Chronic Pain in the Emergency Department: Results of the 2014
Academic Emergency Medicine
Consensus Conference Pain Section
. Academic Emergency Medicine 21:12, pages 1421-1430.
Crossref
Crossref
Megan M. Moran-Santa Maria, Julianne Flanagan & Kathleen Brady. (2014) Ovarian Hormones and Drug Abuse. Current Psychiatry Reports 16:11.
Crossref
Crossref
Monica Bawor, Brittany B. Dennis, M. Constantine Samaan, Carolyn Plater, Andrew Worster, Michael Varenbut, Jeff Daiter, David C. Marsh, Dipika Desai, Meir Steiner, Rebecca Anglin, Margaret Coote, Guillaume Pare, Lehana Thabane & Zainab Samaan. (2014) Methadone induces testosterone suppression in patients with opioid addiction. Scientific Reports 4:1.
Crossref
Crossref
T-K Clarke, R C Crist, A Ang, L M Ambrose-Lanci, F W Lohoff, A J Saxon, W Ling, M P Hillhouse, R D Bruce, G Woody & W H Berrettini. (2013) Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. The Pharmacogenomics Journal 14:3, pages 303-308.
Crossref
Crossref
Caroline Davis, Robert D. Levitan, Allan S. Kaplan, James L. Kennedy & Jacqueline C. Carter. (2014) Food cravings, appetite, and snack-food consumption in response to a psychomotor stimulant drug: the moderating effect of “food-addictionâ€. Frontiers in Psychology 5.
Crossref
Crossref
Paolo Mannelli, Li-Tzy Wu, Kathleen S. Peindl, Marvin S. Swartz & George E. Woody. (2014) Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial. Drug and Alcohol Dependence 138, pages 83-88.
Crossref
Crossref
P. Mannelli, L.-T. Wu, K. S. Peindl & D. A. Gorelick. (2013) Smoking and Opioid Detoxification: Behavioral Changes and Response to Treatment. Nicotine & Tobacco Research 15:10, pages 1705-1713.
Crossref
Crossref
R. Kathryn McHugh, Elise E. DeVito, Dorian Dodd, Kathleen M. Carroll, Jennifer Sharpe Potter, Shelly F. Greenfield, Hilary Smith Connery & Roger D. Weiss. (2013) Gender differences in a clinical trial for prescription opioid dependence. Journal of Substance Abuse Treatment 45:1, pages 38-43.
Crossref
Crossref
L.C. Harte-Hargrove, N.J. MacLusky & H.E. Scharfman. (2013) Brain-derived neurotrophic factor–estrogen interactions in the hippocampal mossy fiber pathway: Implications for normal brain function and disease. Neuroscience 239, pages 46-66.
Crossref
Crossref
Jincai He, Ying Xie, Jingyan Tao, Hang Su, Wenxiu Wu, Shengzhen Zou, Jiajia Zhang, Jie Zhang, Hailing Zhang, Xiaofei Yang, Jun Guo, Wei Tang, Feixue Zhang, Jiahong Liu, Linjing Liu, Yuanling Chen, Na Wen, Thomas R. Kosten & Xiang Yang Zhang. (2013) Gender differences in socio-demographic and clinical characteristics of methamphetamine inpatients in a Chinese population. Drug and Alcohol Dependence 130:1-3, pages 94-100.
Crossref
Crossref
Cynthia Wei-Sheng Lee & Ing-Kang Ho. (2013) Sex Differences in Opioid Analgesia and Addiction: Interactions among Opioid Receptors and Estrogen Receptors. Molecular Pain 9, pages 1744-8069-9-45.
Crossref
Crossref
Rouhollah Qurishi, Christina Sonneborn, Marieke de Jong-Arts & Cornelis de Jong. (2013) Premenstrual Syndrome and Self-Medication With Opioids. Journal of Addiction Medicine 7:1, pages 79-82.
Crossref
Crossref
Richard J. Bodnar. (2012) Endogenous opiates and behavior: 2011. Peptides 38:2, pages 463-522.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Psychiatry 25:6, pages 565-573.
Crossref
Crossref
Michelle A. Skinner, Eleanor T. Lewis & Jodie A. Trafton. (2012) Opioid Use Patterns and Association with Pain Severity and Mental Health Functioning in Chronic Pain Patients. Pain Medicine 13:4, pages 507-517.
Crossref
Crossref
Mohammad Sami Walid, Nadezhda Zaytseva, Moataz Abbara & Azhar Abdullah. (2012) The Relationship between Recurrent Spine Surgery and Employment Status. Open Journal of Modern Neurosurgery 02:01, pages 11-15.
Crossref
Crossref
Michael M. Morgan & Kristin Ataras. (2022) Sex Differences in the Impact of Pain, Morphine Administration and Morphine Withdrawal on Quality of Life in Rats. SSRN Electronic Journal.
Crossref
Crossref